Kürzinger, M., Douarin, L., Uzun, I., El-Haddad, C., Hurst, W., Juhaeri, J., & Tcherny-Lessenot, S. (2020). Structured benefit–risk evaluation for medicinal products: Review of quantitative benefit–risk assessment findings in the literature. Ther Adv Drug Saf.
Citação norma ChicagoKürzinger, Marie-Laure, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, and Stéphanie Tcherny-Lessenot. "Structured Benefit–risk Evaluation for Medicinal Products: Review of Quantitative Benefit–risk Assessment Findings in the Literature." Ther Adv Drug Saf 2020.
Deismireacht MLAKürzinger, Marie-Laure, et al. "Structured Benefit–risk Evaluation for Medicinal Products: Review of Quantitative Benefit–risk Assessment Findings in the Literature." Ther Adv Drug Saf 2020.